🇨🇭 Switzerland Country × Condition
coronary artery disease Clinical Trials in Switzerland
Active clinical trials for coronary artery disease with research sites in Switzerland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇨🇭 Switzerland
Active Trials in Switzerland (4)
NCT06710210
Recruiting
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
Enrollment
150 pts
Country
🇨🇭 Switzerland
University Hospital, Geneva
View Trial → NCT07276282 Phase 3
Recruiting
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Enrollment
332 pts
Country
🇨🇭 Switzerland
ECRI bv
View Trial → NCT04808401
Recruiting
Influence of Oxygen on Perioperative Outcome in Patients Undergoing General Anaesthesia for Elective Non-cardiac Surgery
Enrollment
110 pts
Country
🇨🇭 Switzerland
Insel Gruppe AG, University Hospita...
View Trial → NCT06559332
Recruiting
Coronary Artery Disease Assessment Strategies in TAVI Patients
Enrollment
546 pts
Country
🇨🇭 Switzerland
Insel Gruppe AG, University Hospita...
View Trial → Frequently Asked Questions
How many coronary artery disease clinical trials are active in Switzerland?
There are currently 4 active clinical trials for coronary artery disease with sites in Switzerland, of which 4 are actively recruiting patients.
How can I join a coronary artery disease clinical trial in Switzerland?
To join a coronary artery disease clinical trial in Switzerland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Switzerland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are coronary artery disease trials in Switzerland?
Active coronary artery disease trials in Switzerland span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology